eAbbvie
Pharmaceutical Product Catalog

Effective January 1, 2019, VIEKIRA XR and TECHNIVIE will no longer be available in the U.S.A. Until January 1, 2019, supply of these medications will be available for all patients who begin therapy prior to July 1, 2018, to ensure that they are able to obtain product necessary to complete their course of prescribed therapy. Accordingly, AbbVie advises that physicians should cease writing any new prescriptions for VIEKIRA XR and TECHNIVIE effective July 1, 2018.

nav nav
KALETRA OS 80MG/20MG/ML 160ML
NDC number: 00074395646
Product Family: KALETRA
Dosage Form: ML
Strength: 400 MG; 100 MG/5ML
Imprint:
Approval Date: 09/05/2000
Controlled Substance: RX
Therapeutic Class:
Anti-HIV Agent (protease inhibitor)
   
Price
List Price: $508.99
List Effective Date: 12/26/2016
WAC Price: $483.54
WAC Effective Date: 12/26/2016
Product Dimensions
Each Length (in): 2.34
Each Width (in): 1.63
Each Height (in): 5.36
Packaging Details
Packaging Information
Unit Of Measure: EACH
Inner Pack:
Quantity / Salable Unit: 160 ML
Case Size: 6
Total Cases / Pallet: 280
Total Pallet Weight (lbs): 932.00
Number of Tiers: 5
Cases / Tier: 56
Case Details
Case Weight (lbs): 3.20
Case Volume (cu ft): 0.15
Length (in) Width (in) Height (in)
Outer Case 6.01 5.63 7.50
Inner Case 5.63 5.25 6.75
Announcements
Additional Information
Product and pricing detail may change. Please return to www.e-abbvie.com for the current product and pricing information.
Copyright © Abbvie Version 2.5